Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 158,286 | 150,452 | 39,604 | 14,598 | 168,607 |
| Receivables | 1,560 | 2,417 | 278 | 158 | 39,379 |
| Inventories | N/A | N/A | N/A | N/A | 257,180 |
| Other current assets | 37,540 | 26,267 | 5,795 | 10,043 | 94,153 |
| TOTAL | $197,386 | $179,136 | $45,677 | $24,799 | $559,319 |
| Non-Current Assets | |||||
| PPE Net | 10,504 | 4,472 | 1,743 | 1,605 | 229,365 |
| Intangibles | 3,563 | 3,563 | 0 | 0 | 0 |
| Other Non-Current Assets | 931 | 50 | 27 | 129 | 0 |
| TOTAL | $14,998 | $8,085 | $1,770 | $1,734 | $229,365 |
| Total Assets | $212,384 | $187,221 | $47,447 | $26,533 | $1,017,926 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 4,203 | N/A | N/A |
| Accounts payable and accrued liabilities | 29,496 | 10,798 | 3,685 | 3,902 | 0 |
| Accrued Expenses | 24,133 | 11,231 | 7,258 | 3,588 | N/A |
| Other current liabilities | 2,768 | 6,954 | 24,272 | 1,738 | N/A |
| TOTAL | $106,018 | $51,783 | $53,701 | $11,253 | $261,979 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 133,639 |
| Deferred Revenues | 49,621 | 22,800 | 14,283 | 2,025 | N/A |
| Other Non-Current Liabilities | 68,635 | 28,826 | 7,561 | 12 | 0 |
| TOTAL | $113,295 | $68,681 | $36,128 | $6,088 | $133,639 |
| Total Liabilities | $219,313 | $120,464 | $89,829 | $17,341 | $600,980 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,103 | 33,324 | N/A | N/A | N/A |
| Common Shares | 4 | 3 | 1 | 1 | N/A |
| Retained earnings | -409,985 | -186,725 | -99,592 | -45,957 | 236,720 |
| Other shareholders' equity | -1,123 | -569 | 54,695 | 54,695 | 180,226 |
| TOTAL | $-6,929 | $66,757 | $-42,382 | $9,192 | $416,946 |
| Total Liabilities And Equity | $212,384 | $187,221 | $47,447 | $26,533 | $1,017,926 |